Annexon, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders.
Annexon stock last closed at $6.25, down 1.12% from the previous day, and has increased 161.86% in one year. It has overperformed other stocks in the Biotechnology industry by 1.69 percentage points. Annexon stock is currently +298.09% from its 52-week low of $1.57, and -25.6% from its 52-week high of $8.40.
As of Sep 10, 2024, there are 105.65M shares of ANNX outstanding. The market value of ANNX is $660.34M. In the last 24 hours, 573,823 ANNX shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy ANNX stock.
Based on our research, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal details so you can invest in ANNX today.
Now that you have finished signing up on one of the best stock trading apps, you need to deposit funds:
Check out the tutorial below if you need help depositing funds into your brokerage account.
Once you have chosen the best place to buy Annexon stock, it's very important to research their stock prior to investing, so you truly wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help everyday investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ANNX's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge ANNX's intrinsic value.
Using relative valuations metrics:
You can do additional valuation analysis on ANNX's stock here.
Out of 5 sell side analysts who give ratings on ANNX, the consensus analyst rating on Annexon is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Annexon stock forecast page.
Over the last year, executives and large shareholders at ANNX have bought more shares than they have sold.
Ted Yednock, EVP CHIEF INNOVATION OFFICER of ANNX, was the latest ANNX insider to sell. They sold $31,020.00 worth of ANNX stock on Sep 5, 2024.
Get more info about who owns ANNX stock here.
No, Annexon doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two main options:
Hit the Open button and your broker will place the order.
If you require more assistance investing in stocks on eToro, click the helpful video below:
Now that you own some ANNX stock, you'll want to stay up-to-date on your new investment.
Start a watchlist to monitor your ANNX stock.
To reiterate, here are the 6 steps for buying Annexon stock:
If you require a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Annexon, add ANNX to your watchlist below.